Xi'An International Medical Investment (000516.SZ) has received approval from the China Securities Regulatory Commission for its application to issue stocks to specific targets.
International Medical (000516.SZ) announced that on September 7, 2026, it received a reply from the China Securities Regulatory Commission regarding the approval of Xi'an International Medical Investment Co., Ltd.'s application for the registration of stock issuance to specific objects, agreeing to the company's registration application for issuing stocks to specific parties.
Xi'An International Medical Investment (000516.SZ) announced that on September 7, 2026, it received a reply from the China Securities Regulatory Commission regarding the approval of Xi'An International Medical Investment Co., Ltd.'s application for the registration of stock issuance to specific targets, agreeing to the company's application for the registration of stock issuance to specific targets.
Related Articles
Wu Deqing, the vice president of Anhui Shenjian New Materials (002361.SZ), has been investigated by the China Securities Regulatory Commission for suspected insider trading.
GLOBALSTRAT (08007) has signed a memorandum of understanding with JD Trading Group Limited to jointly develop a digital information platform for the clean energy and engineering equipment industry.
XTALPI (02228) spent HKD 2.1394 million to repurchase 299,000 shares on September 7.
Wu Deqing, the vice president of Anhui Shenjian New Materials (002361.SZ), has been investigated by the China Securities Regulatory Commission for suspected insider trading.
GLOBALSTRAT (08007) has signed a memorandum of understanding with JD Trading Group Limited to jointly develop a digital information platform for the clean energy and engineering equipment industry.
XTALPI (02228) spent HKD 2.1394 million to repurchase 299,000 shares on September 7.
RECOMMEND
